Fitzgerald Joseph Michael (CIK 1484186) reported 44 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-18). Recent activity: Buy BSX (34,898 shares), Buy BSX (34,898 shares), Buy BSX (2,797 shares), Sell BSX (33,104 shares), Buy BSX (4,362 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-18 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Buy | 34,898 | $0 |
| 2026-02-18 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Buy | 34,898 | $0 |
| 2026-02-18 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Buy | 2,797 | $0 |
| 2026-02-18 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Sell | 33,104 | $2.5M |
| 2026-02-18 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Buy | 4,362 | $0 |
| 2026-02-18 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Sell | 1,990 | $148,713 |
| 2026-02-18 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Buy | 3,960 | $0 |
| 2026-02-18 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Sell | 1,806 | $134,962 |
| 2026-02-17 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Buy | 3,462 | $0 |
| 2026-02-17 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Sell | 1,612 | $119,481 |
| 2025-11-14 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Sell | 690 | $0 |
| 2025-11-14 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Sell | 9,610 | $0 |
| 2025-11-04 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Buy | 50,000 | $1.3M |
| 2025-11-04 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Sell | 3,600 | $362,700 |
| 2025-11-04 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Sell | 16,928 | $1.7M |
| 2025-11-04 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Sell | 29,472 | $2.9M |
| 2025-10-01 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Buy | 50,000 | $1.3M |
| 2025-10-01 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Sell | 8,245 | $815,513 |
| 2025-10-01 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Sell | 41,755 | $4.1M |
| 2025-09-03 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Buy | 50,000 | $1.3M |
| 2025-09-03 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Sell | 21,830 | $2.3M |
| 2025-09-03 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Sell | 28,170 | $3.0M |
| 2025-08-04 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Buy | 50,000 | $1.3M |
| 2025-08-04 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Sell | 50,000 | $5.2M |
| 2025-07-02 | BOSTON SCIENTIFIC CORP (BSX) | EVP & Group Pres, Cardiology | Buy | 50,000 | $1.3M |
Source: SEC Form 4 filings · as of 2026-02-18